Tony Lough
87 St David Street
Dunedin, OTA 9016, New Zealand
Dunedin, OTA 9016, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study.
Journal: Urologic oncology
Published: July 01, 2025
A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.
Journal: The Journal of urology
Published: May 03, 2024
Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria.
Journal: The Journal of urology
Published: December 28, 2020
Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy.
Journal: European urology
Published: August 24, 2018
Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician-Patient Real-World Clinical Data Analysis.
Journal: Oncology and therapy
Published: February 15, 2018
Clinical utility of a non-invasive urine test for risk assessing patients with no obvious benign cause of hematuria: a physician-patient real world data analysis.
Journal: BMC urology
Published: July 31, 2017
Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma.
Journal: Advances in therapy
Published: February 22, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026